Filter Results:
(249)
Show Results For
- All HBS Web
(249)
- News (56)
- Research (170)
- Events (3)
- Multimedia (3)
- Faculty Publications (58)
Show Results For
- All HBS Web
(249)
- News (56)
- Research (170)
- Events (3)
- Multimedia (3)
- Faculty Publications (58)
- 01 Jun 2010
- News
$how Me the Money
Bank made a $160 million settlement with the Justice Department, agreeing it had been lax about accepting drug money from Mexico.) While U.S. law is tough on drug trafficking, terrorist financing, bank... View Details
- 12 Feb 2019
- First Look
New Research and Ideas, February 12, 2019
Devices: Challenges and Opportunities for U.S. Regulators and Innovators By: Gordon, William J., and Ariel Dora Stern Abstract— Software has become an increasingly important component of medical device technology. Through legislation like the 21st Century Cures Act as... View Details
Keywords: Dina Gerdeman
- 03 Mar 2009
- First Look
First Look: March 3, 2009
crucially so—on whether or not the platforms subsidize one side of the market in equilibrium. For example, with prices being strategic complements across platforms, we show that a cost-reducing investment by one firm may have a positive... View Details
Keywords: Martha Lagace
- 01 Mar 2014
- News
Feedback
bulletin@hbs.edu. Write us a letter. This is your magazine. It needs your voice. Gene Williams, featured in the December 2013 HBS Alumni Bulletin Top Story The story of Gene Williams (MBA 1987) and his new drug development model hit a... View Details
Keywords: Health, Social Assistance
- 16 Oct 2013
- Op-Ed
Response to Readers: Combating Climate Change with Nuclear Power and Fracking
With more than 7,500 views and 180-plus tweets, I want to thank everyone for taking the time to read the original HBS Working Knowledge piece, The Case for Combating Climate Change with Nuclear Power and Fracking, and, in particular, for sharing your thoughts with one... View Details
- 09 Sep 2014
- First Look
First Look: September 9
patient. Schrader and his colleagues had to decide on which vaccines to focus and whether and how to target the drug companies that manufactured the vaccines or the quasi-government organizations (such as UNICEF and PAHO) and... View Details
Keywords: Sean Silverthorne
- 13 Jul 2009
- Research & Ideas
Diagnosing the Public Health Care Alternative
multiplied by a marginal Federal borrowing cost of 3 percent), eliminating any price advantage of Medicare. The comparison between the administrative expenses of private insurers and Medicare also ignores the fact that Medicare pays no... View Details
- 27 Mar 2012
- First Look
First Look: March 27
Tanzania are more expensive than comparable hotels, and that this difference in price cannot be accounted for by differences in supply constraints. Further, using cross-country panel data, I show that upscale hotel View Details
Keywords: Carmen Nobel
- 02 Sep 2008
- First Look
First Look: September 3, 2008
powerhouse, went sour at VW, as a top manager secured key concessions by paying for union leaders' lavish foreign travel and visits to prostitutes. After vitamin prices sagged in the late 1980s, BASF and the Swiss chemical firm... View Details
Keywords: Sean Silverthorne
- 01 Feb 2001
- News
Q&A - Dirty Money: Raymond Baker Explores the Free Market's Demimonde
transaction prices and bank deposits — that carry stiff penalties if violated. What are the attitudes overseas about U.S. enforcement efforts? The perception is widespread in developing and transitional economies that the West, including... View Details
- 18 Apr 2017
- First Look
First Look at New Ideas, April 18
M&A) and Werner Baumann (CFO) have to decide whether to increase the cash portion of their $14.2 billion offer and/or amend the terms of a proposed joint venture (JV) with Merck involving cardiovascular drugs that had been included in... View Details
Keywords: by Sean Silverthorne
- 28 Apr 2009
- First Look
First Look: April 28, 2009
consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based... View Details
Keywords: Martha Lagace
- 25 Aug 2014
- News
Wendell P. Weeks, MBA 1987
appealed to Weeks when he arrived at Corning as a Price Waterhouse consultant after graduating from Lehigh University. “I was impressed with the people and what the company stood for,” he recalls. The feeling was mutual: Corning asked him... View Details
Keywords: Susan Young
- 29 May 2001
- Research & Ideas
How Technological Disruption Changes Everything
market where customers are being overserved by the prevailing offerings. The concept of "overshooting" suggests that companies try to keep prices and margins high by developing products with many more features than customers can... View Details
- 23 Mar 2010
- First Look
First Look: March 23
Publications "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance Author: Arthur A. Daemmrich Publication: Chap. 13 in The Fragmentation of U.S. Health Care, Oxford University Press, 2010 Abstract Adverse View Details
Keywords: Martha Lagace
- 12 Apr 2018
- Op-Ed
Op-Ed: The Trouble with Tariffs
active ingredients for anti-nausea drugs, even the drug inside an EpiPen. There were also more mundane items like milking machine parts and telescopic gunsights for rifles. The careful selection avoided high-profile items like smartphones... View Details
Keywords: by Willy C. Shih; Manufacturing; Auto; Steel; Air Transportation; Technology; Telecommunications
- 01 May 2007
- First Look
First Look: May 1, 2007
FDI increase when we account for the quality of FDI. Download working paper: http://www.hbs.edu/research/pdf/07-072.pdf The Price of Capital: Evidence from Trade Data Authors:Laura Alfaro and Faisal Z. Ahmed Abstract In this paper we use... View Details
Keywords: Sean Silverthorne
- 24 Sep 2020
- News
The Race for a Vaccine
Pisano says. But vaccines don’t really fit the same business model as high-volume therapeutic drugs; they have an even higher bar for safety and effectiveness, because unlike most other drugs they are administered to healthy populations.... View Details
- 18 Nov 2014
- First Look
First Look: November 18
innovative drug candidates for testing in patients. Project teams consisted of Pfizer scientists and academics working side-by-side to reduce the time needed to bring a therapeutic drug from the lab to a... View Details
Keywords: Sean Silverthorne
- 03 Jan 2017
- First Look
January 3, 2017
to standardize their products and helped establish brand identities through consistent appearance. By 1938, food dyes had achieved such widespread use, and had raised such public concern, that the federal government amended the 1906 Pure Food and View Details
Keywords: Carmen Nobel